KMO activity is upregulated in several brain regions of HD model mice [10], and normalisation of KP metabolic imbalance via KMO inhibition ameliorates disease-relevant phenotypes in several models of HD and other neurodegenerative disorders [11,12,13,14,15,16]. The gene discussed is KMO; the disease is Huntington disease.